Clinical Trials

Takeda prioritizes clinical research transparency by making our research information and results available to the public.

Discover Takeda Clinical Trials

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our unwavering commitment to putting patients first guides our scientific discovery and helps us as we strive to address unmet medical needs.

Learn more about Takeda clinical trials below.

Investigator-Initiated Research

Our Investigator-Initiated Research program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest.

Access to Investigational Medicines

Medicines undergoing clinical development are often referred to as “investigational medicines” before approval by a regulatory body such as the Food and Drug Administration (FDA) for the United States. The use of investigational medicine outside of a clinical trial is known as Pre-Approval Access or Expanded Access (sometimes also referred to as compassionate use).